JAMA Network Open 研究显示三分之一在线非处方护肤产品含未申报强效激素
Undeclared pharmacologically active ingredients ID'd in OTC skin products
10月8日发表于 JAMA Network Open 的研究对18款在线销售的非处方(OTC)皮肤护理产品进行靶向评估,在其中6款(33.3%)检出未申报的药理活性成分(UPAIs),且每款阳性产品的三个分析单元均检出。
针对在线OTC护肤品的靶向检测显示三分之一含未申报强效激素,提示监管盲区和患者暴露风险。
Undeclared pharmacologically active ingredients (UPAIs) are detected in one-third of over-the-counter (OTC) skin products marketed online, according to a study published online Oct. 8 in JAMA Network Open.
Zaur Abilov, M.D., from Beth Israel Deaconess Medical Center in Boston, and colleagues performed a targeted assessment to examine the presence of UPAIs in 18 OTC skin products marketed online.
The researchers identified UPAIs in six of the preselected products (33.3%) and in all three analyzed units of each of the positive products. Six products contained the superpotent (class I) prescription-only corticosteroid clobetasol propionate; two also included the antifungals miconazole or terbinafine. There was variation in detected concentrations of clobetasol propionate, ranging from about 0.01% to 0.46%; the highest concentrations were 9.2-fold higher than those in U.S. Food and Drug Administration-approved topical formulations.
Product labels did not disclose any of these clinically proven active ingredients. Across online retail platforms, products that tested positive had more than 10,000 combined user reviews.
"FDA states that its health fraud database covers only a small fraction of contaminated products on the market," the authors write. "As a result, products containing UPAIs, including superpotent corticosteroids, may remain available to consumers until they are identified through targeted surveillance or adverse-event reporting. Patients and the medical community should be aware of the potential risks associated with UPAI exposure from the use of OTC products for chronic skin conditions."
Publication details
Zaur Abilov et al., Undeclared Pharmacologically Active Ingredients in Over-the-Counter Skin Products, JAMA Network Open (2026). DOI: 10.1001/jamanetworkopen.2026.38654
Journal information: JAMA Network Open
Who's behind this story?
Gaby Clark
MA in English, copy editor since 2021 with experience in higher education and health content. Dedicated to trustworthy science news. Full profile →
Alexander Pol
PhD nano-engineering from Delft University. Published researcher and journal reviewer. Brings scientific insight to content standards. Full profile →
© 2026 HealthDay. All rights reserved.
Citation: Undeclared pharmacologically active ingredients ID'd in OTC skin products (2026, October 15) retrieved 15 October 2026 from https://medicalxpress.com/news/2026-10-undeclared-pharmacologically-ingredients-idd-otc.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.
来源:Medical Xpress · medicalxpress.com